David Adler currently serves as the Vice President of Business Development at Sarah Cannon Research Institute since November 2022 and at US ONCOLOGY RESEARCH, LLC since August 2021. Previously, David held various roles at McKesson, including Executive Director of Business Development for US Oncology Research and Director of Business Development since August 2009. David's earlier experience includes a position as Senior Market Development Manager for Medical Groups at GlaxoSmithKline from 1992 to 2009. David holds a Bachelor of Arts degree in Speech Communications from California State University, Northridge, obtained between 1982 and 1987.
This person is not in any teams
This person is not in any offices